CN117384759A - Micro-needle array-based organoid culture method - Google Patents
Micro-needle array-based organoid culture method Download PDFInfo
- Publication number
- CN117384759A CN117384759A CN202311653619.8A CN202311653619A CN117384759A CN 117384759 A CN117384759 A CN 117384759A CN 202311653619 A CN202311653619 A CN 202311653619A CN 117384759 A CN117384759 A CN 117384759A
- Authority
- CN
- China
- Prior art keywords
- culture
- organoid
- piece
- micro
- organoids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002220 organoid Anatomy 0.000 title claims abstract description 126
- 238000012136 culture method Methods 0.000 title claims abstract description 19
- 239000001963 growth medium Substances 0.000 claims abstract description 33
- 210000001519 tissue Anatomy 0.000 claims abstract description 23
- 230000005484 gravity Effects 0.000 claims abstract description 11
- 239000002609 medium Substances 0.000 claims description 32
- 230000002025 microglial effect Effects 0.000 claims description 22
- 238000012258 culturing Methods 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 15
- 238000004113 cell culture Methods 0.000 claims description 14
- 108010082117 matrigel Proteins 0.000 claims description 14
- 210000000056 organ Anatomy 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 238000005192 partition Methods 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 238000003825 pressing Methods 0.000 claims description 2
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 claims 1
- 238000003501 co-culture Methods 0.000 abstract description 12
- 238000011160 research Methods 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 4
- 238000000338 in vitro Methods 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000012423 maintenance Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 38
- 210000002889 endothelial cell Anatomy 0.000 description 12
- 210000000130 stem cell Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 210000000274 microglia Anatomy 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 102100040121 Allograft inflammatory factor 1 Human genes 0.000 description 2
- 101000890626 Homo sapiens Allograft inflammatory factor 1 Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000010146 3D printing Methods 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000009762 endothelial cell differentiation Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000004129 prosencephalon Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000030968 tissue homeostasis Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Molecular Biology (AREA)
- Clinical Laboratory Science (AREA)
- Cell Biology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
The present invention relates to the field of culture or maintenance of undifferentiated human, animal or plant cells, such as cell lines, and in particular to a microneedle array based organoid culture method. The micro-needle array-based organoid culture method of the invention uses an organoid culture device, and comprises the following steps: 1) Placing the organoids in the lower part for culture; 2) The middle piece is arranged above the lower piece, cells are added into the middle piece, and the cells are mixed with a passage formed by a culture medium through a microneedle array, are transferred to the organoid positioned at the tail end of the microneedle by utilizing gravity, and are diffused into the organoid tissue through an opening at the tail end of the microneedle. The invention is based on the microneedle array, realizes the co-culture of cell tissues and organoids by utilizing a spliced and inserted combination mode, can realize the co-culture of cells and organoids or different organoids which are controllably combined in vitro in a controllable range, and provides a basis for the subsequent research of multi-organ combined treatment and the research of human development.
Description
Technical Field
The present invention relates to the field of culture or maintenance of undifferentiated human, animal or plant cells, such as cell lines, and in particular to a microneedle array based organoid culture method.
Background
In the last decade scientists have taken advantage of the ability of stem cells to self-renew and produce differentiated cells by which all tissues of developing embryos can be produced and tissue homeostasis of adults maintained. These key stem cell features have been exploited to develop "micro-organs", so-called organoids, in vitro. Organoids are 3D cultures derived from stem cells and derived from tissues, whose phenotype cell type composition, structure, and, to some extent, function of different tissues. Multiple organoid models have been developed in vivo, such as brain organoids in different areas (whole brain, forebrain, cerebellum, etc.), kidney organoids, intestine organoids, heart organoids, lung organoids, skin organoids, etc. Organoids have significant advantages in many aspects such as cancer, genetic diseases and the like, and in many aspects such as drug screening.
Traditional organoids were cultured on 6-well plates or 10cm plates, lacking the necessary interconnections. But with the development of micro 3D printing and micro engineering technology, the development of organoid chips is realized. An "organ-chip" is a micro-engineering biomimetic system comprising microfluidic channels lined by living human cells that reproduce the critical functional units of living organs to reconstruct the integrated human organ-level pathophysiology in vitro. These microdevices can be used to test the efficacy and toxicity of drugs and chemicals and create in vitro models of human diseases. Thus, they may represent a low cost alternative to traditional animal models for pharmaceutical, chemical and environmental applications. However, the realization of the whole body on the chip is reported recently.
During organoid culture, multiple organoid fusion culture is difficult to realize due to the problems of organoid central necrosis caused by insufficient supply of central nutrients and oxygen, lack of migration capability of tissue cells and the like, and thus organoids with diversified components are obtained. When the traditional chip is used for performing organoid co-culture, organoids are required to be taken out from a previous culture medium, then different organoids are mixed with cold Matrigel, and then the organoids are placed in the organoid co-culture chip, or the organoids are closely attached to cells with migration capability, and diversified organoids such as vascularized or immunocyte-containing organoids are obtained through the self migration capability of tissue cells, so that the whole operation process is tedious and low-efficiency. There is therefore a need for a method that can achieve rapid, multiple species, reliable delivery of co-cultures at the organoid level, resulting in tissue-diversified organoids.
Disclosure of Invention
The invention aims to provide a micro-needle array-based organoid culture method capable of realizing cell migration.
The invention provides a micro-needle array-based organoid culture method, which uses an organoid culture device, wherein the organoid culture device comprises a lower piece for culturing organoids and a middle piece for culturing cell tissues; the lower part is detachably connected with the middle part, and the cell tissues cultured in the middle part are communicated with the organoids in the lower part through the microneedles; the method comprises the following steps:
1) Placing the organoids in the lower part for culture;
2) The middle piece is arranged above the lower piece, cells are added into the middle piece, and the cells and the culture medium pass through a micro-needle passage, are transferred to the organoid at the tail end of the micro-needle by utilizing gravity, and are diffused into the organoid through the opening at the tail end of the micro-needle.
Further, step 3) is included in which the organoid of the lower member is mixed with the cells, and then the upper member is covered over the middle member, followed by culturing.
Further, the lower part comprises a lower part base and a lower part base platform connected above the lower part base, a culture tank with an opening at the upper end is arranged on the base platform, and at least one organoid placing hole is arranged in the culture tank; a group partition plate is arranged between two adjacent organoid placing holes, the group partition plate is connected with the bottom wall of the culture tank, and a hole is arranged between the group partition plate and the side wall of the culture tank; the culture medium feeding device is characterized in that a lower culture medium feeding groove is arranged on the base, and the lower culture medium feeding groove is positioned on two sides of the culture groove and is communicated with the culture groove through a culture medium inlet.
Further, positioning piles are arranged around the organoid placing holes; one side of the base station is provided with a positioning fillet.
Further, the well piece includes well piece base and connects the well piece base in well piece base top, the position that corresponds with the culture tank of piece down on the well piece base is equipped with well piece U-shaped liquid feeding groove, well piece U-shaped liquid feeding groove (the bottom surface is the arc, and the cell tissue of being convenient for utilizes gravity effect to sink, communicates to organoid, for example the organoid tissue through the microneedle array) in be equipped with at least one well piece cell culture room, the below of well piece cell culture room is connected with the microneedle array, well piece cell culture room is linked together with the microneedle array, and when well piece was linked together with the piece down, the lower extreme of microneedle array inserts in the organoid of cultivating on the organoid placing hole.
Further, the middle piece base is provided with an upward concave groove matched with the edge of the lower piece base, and the side, corresponding to the positioning fillet, of the groove and the lower piece base is provided with an arc inner angle.
Further, the device includes a top piece for the closure device, the top piece being removably connected to the middle piece.
Further, the upper part is a cover body connected above the middle part, and an upper cover supporting block is arranged on the inner surface of the cover body; one side of the middle part base station is a round angle, and one side of the upper part corresponding to the round angle of the middle part base station is provided with an arc inner angle.
Further, the step 1) specifically includes: 11 Input matrigel): firstly, injecting matrigel into an organoid placing hole of a lower piece by using a liquid transfer device;
12 Placement of organoids: carefully placing the organoids in organoid placement holes filled with matrigel;
13 Injection medium: organoid medium was placed into the organoid through the lower feed tank Kong Jiazhu medium.
Further, the step 2) specifically includes:
21 Positioning round corners of the middle piece and the lower piece to be aligned, and slowly pressing the middle piece into the lower piece;
22 Culturing microglial cells in medium: transferring a culture medium of microglial cells into a middle piece U-shaped liquid adding groove, and sequentially inoculating the microglial cells into a middle piece cell culture chamber by using a liquid transfer device;
23 Microglial cell-mixed culture medium is transferred to the organoid at the end of the microneedle through the microneedle channel by gravity and is diffused into the organoid through the opening at the end of the microneedle.
Further, the culturing method in the step 3) is as follows: the remaining amount of medium, if any, of the medium in the daily inspection was removed with a pipette and 4ml of medium was added again; every 3 days, 20ml of medium was changed through the lower piece of the liquid-feeding channel (only through the middle piece). The culture conditions are as follows: placed in 5% CO 2 Culturing was performed at 37℃in an incubator.
The invention is based on micro-processing technology and micro-needle array, and can realize co-culture of cell tissue and organoid by utilizing a spliced and inserted combination mode, and can perform co-culture of cells and organoid or different organoids in vitro in a controllable range and controllable combination, so as to reproduce and research the reaction of a plurality of organs or tissues to medicines and toxins, and provide a basis for subsequent research of multi-organ combined treatment and research of human development.
Drawings
FIG. 1 is an exploded view of the organoid culture device of the invention.
Fig. 2 is a bottom view of the upper of the present invention.
Fig. 3 is a top view of the middle of the present invention.
Fig. 4 is a bottom view of the middle piece of the present invention.
Fig. 5 is a short side cross-sectional view of the middle piece of the present invention.
Fig. 6 is a perspective view of the lower piece of the present invention.
Fig. 7 is a cross-sectional view of the lower member of the present invention.
FIG. 8 is a graph showing the fluorescence detection results in example 1.
FIG. 9 is a graph (10X) showing the fluorescence detection results of the co-culture of endothelial cells and brainstorming balls in example 2.
FIG. 10 is a graph (100X) showing the fluorescence detection results of the co-culture of endothelial cells and brainstorming balls in example 2.
Reference numerals illustrate: 1. lower part, lower part base, 12, lower part base, 13, culture tank, 14, organoid placement hole, 15, positioning pile, 16, group baffle, 17, lower part culture medium feeding tank, 18, culture medium inlet, 19, positioning fillet, 2, middle part, 21, middle part base, 22, middle part base, 23, middle part U-shaped feeding tank, 24, middle part cell culture chamber, 25, microneedle array, 26, through hole, 27, groove, 3, upper part, 31, cover, 32, upper cover support block.
Detailed Description
The following detailed description of the invention is provided in connection with the accompanying drawings that are presented to illustrate the invention and not to limit the scope thereof. The examples provided below are intended as guidelines for further modifications by one of ordinary skill in the art and are not to be construed as limiting the invention in any way.
The experimental methods in the following examples, unless otherwise specified, are conventional methods, and are carried out according to techniques or conditions described in the literature in the field or according to the product specifications. Materials, reagents and the like used in the examples described below are commercially available unless otherwise specified.
As shown in fig. 1 to 7, the present invention provides an organoid culture device comprising a lower member 1 for culturing organoids, a middle member 2 for culturing cellular tissue, and an upper member 3 for closing the device; the lower part 1 is detachably connected with the middle part 2, and the tissue cultured in the middle part 3 is communicated with the organoids in the lower part 1 through the microneedle array 25.
The lower part 1 comprises a lower part base 11 and a lower part base 12 connected above the lower part base 11, a culture tank 13 with an opening at the upper end is arranged on the lower part base 12, at least one organoid placing hole 14 is arranged in the culture tank 13, and positioning piles 15 are arranged around the organoid placing hole 14; a group partition plate 16 is arranged between two adjacent organoid placing holes 14, the group partition plate 16 is connected with the bottom wall of the culture tank 13, and a hole is reserved between the group partition plate 16 and the side wall of the culture tank 13 (the hole is smaller than the organoid size, such as the diameter of the organoid); the culture medium feeding grooves 17 are arranged on the base, and the culture medium feeding grooves 17 are positioned on two sides of the culture grooves and are communicated with the culture grooves through culture medium inlet openings 18.
The culture medium inlet 18 is positioned at the bottom of the liquid adding tank, and the height of the culture medium inlet 18 is slightly higher than the bottom of the culture tank, so that the communication and the complete outflow of the liquid in the liquid adding tank are ensured, and the waste is avoided.
One side of the lower piece base 11 is provided with a positioning fillet 19.
The middle part 2 comprises a middle part base 21 and a middle part base 22 connected above the middle part base 21, a middle part U-shaped liquid adding groove 23 is arranged on the middle part base 22 at a position corresponding to the culture groove 13 of the lower part, at least one middle part cell culture chamber 24 is arranged in the middle part U-shaped liquid adding groove 23 (the bottom surface is arc-shaped, so that cell tissues sink under the action of gravity and are communicated into brain-like tissues and other organs through a microneedle array), a microneedle array 25 is connected below the middle part cell culture chamber 24, and the middle part cell culture chamber 24 is communicated with the microneedle array 25; the middle part base 22 is provided with a through hole 26 at a position corresponding to the lower part culture medium feeding groove 17, the bottom of the middle part base 11 is provided with an upward extending groove 27, when the middle part 2 is connected with the lower part 1, the lower part base 22 is inserted into the middle part groove 27, at this time, the through hole 26 is communicated with the lower part culture medium feeding groove 17, the middle part U-shaped feeding groove 23 is positioned right above the culture groove 13, and the lower end of the micro-needle array 25 is inserted into organoid tissues such as brains cultured on the organoid placing hole.
The upper part is a cover body connected above the middle part, an upper cover supporting block is arranged in the cover body, when the upper cover is covered on the middle part, the upper cover supporting block is contacted with the upper surface of the base of the middle part, and a gap for air circulation flows out between the upper cover and the middle part.
The invention also provides a method for culturing the organoid, which uses the organoid culture device and comprises the following steps:
1. placing the organoids in the lower part for culture;
2. mounting the middle piece above the lower piece, adding cells into the middle piece, transferring the cells together with the culture medium to the organoid positioned at the tail end of the microneedle through the microneedle passage by utilizing gravity, and diffusing the cells into the organoid through the opening at the tail end of the microneedle;
3. after mixing the organoids of the lower part with the cells, the upper part is covered over the middle part and then cultured.
The step 1 specifically comprises the following steps: 11 Input matrigel): first, 6ml of cold Matrigel gel (Matrigel) was injected into the organoid placement wells of the lower piece with a pipette, 2ml per well.
12 Placement of organoids: carefully placing the organoids in organoid placement holes filled with matrigel;
13 Injection medium: 30ml of organoid medium was slowly fed through the lower feed tank.
The step 2 specifically comprises the following steps: 21 The middle piece and the lower piece are aligned by positioning fillets, and the middle piece is slowly pressed down into the lower piece 1.
22 Culturing microglial cells in medium: 4ml of microglial culture medium was transferred to a medium U-shaped addition tank, and then microglial cells were sequentially inoculated into 3 cell culture chambers of the medium with a pipette.
23 Microglial cell-mixed culture medium is transferred to the organoid at the end of the microneedle through the microneedle channel by utilizing gravity and is diffused into the organoid tissue through the opening at the end of the microneedle.
In the above devices and methods, the organoid may be a brain-like organ.
The culture method in the step 3) comprises the following steps: the remaining amount of medium, if any, of the medium in the daily inspection was removed with a pipette and 4ml of medium was added again; every 3 days, 20ml of medium was changed through the lower piece of the liquid-feeding channel (only through the middle piece). The culture conditions are as follows: placed in 5% CO 2 Culturing in an incubator at 37 ℃;
during the incubation, samples can be taken at time nodes of day 7 or even longer, as required by the experiment. During sampling, the upper part is taken off, the medium in the middle part is removed, the middle part is lifted upwards slightly, and at the moment, the brain-like organ is attached to the micro needle at the lower end of the middle part and is taken out together.
Example 1
1. Preparation of materials
1. Preparation of brain-like organs
Ipscs (human induced pluripotent stem cells) were differentiated using a brain-like differentiation kit STEMdiff Cerebral Organoid kit (StemCell Technologies, 08570) according to the procedure of STEMCELL TECHNOLOGIES functional net to obtain brain-like organs.
2. Preparation of microglial cells
Ipscs (human induced pluripotent stem cells) were differentiated into cd34+ and cd45+ hematopoietic progenitor cells using stem diff ™ Hematopoietic Kit. The hematopoietic progenitor cells were further induced to culture using a stem diff ™ Microglia kit to obtain microglial cells.
2. Organoid culture
1. Placing the brain-like organ in the lower part for culture; the method comprises the following steps:
11 Input matrigel): first, 6ml of cold Matrigel gel was injected into the organoid placement wells of the lower piece with a pipette, 2ml each.
12 Placement of brain-like organs: carefully placing the organoids in organoid placement holes filled with matrigel;
13 Injection medium: 30ml of organoid medium was slowly fed through the lower feed tank.
The step 2 specifically comprises the following steps: 21 Positioning fillets of the middle piece and the lower piece are aligned, and the middle piece is slowly pressed down to be placed in the lower piece.
2. Mounting the middle piece above the lower piece, adding microglial cells into the middle piece, enabling the cells to be mixed with a culture medium, transferring the culture medium to a brain-like sphere positioned at the tail end of the micro needle by utilizing gravity, and diffusing the culture medium into brain-like tissues through an opening at the tail end of the micro needle; the method comprises the following steps:
21 Positioning fillets of the middle piece and the lower piece are aligned, and the middle piece is slowly pressed down to be placed in the lower piece.
22 Culturing microglial cells in medium: 4ml of microglial culture medium was transferred to a medium U-shaped addition tank, and then microglial cells were sequentially inoculated into 3 cell culture chambers of the medium with a pipette.
23 Microglial cell mixed culture medium is transferred to the brain-like ball at the tail end of the micro needle by utilizing gravity through a micro needle passage and is diffused into brain-like tissue through an opening at the tail end of the micro needle.
3. After the spheroid of the lower part is mixed with cells, the upper part is covered above the middle part, and then the culture is carried out, wherein the culture method comprises the following steps: the remaining amount of medium, if any, of the medium in the daily inspection was removed with a pipette and 4ml of medium was added again; every 3 days, 20ml of medium was changed through the lower piece of the liquid-feeding channel (only through the middle piece). The culture conditions are as follows: placed in 5% CO 2 Culturing in an incubator at 37 ℃;
during the incubation, samples can be taken at time nodes of day 7 or even longer, as required by the experiment. When sampling is carried out, the upper part is taken off, the medium in the middle part is removed, the middle part is lifted upwards slightly, and at the moment, the brain-like ball is attached to the micro needle at the lower end of the middle part and is taken out together.
Immunofluorescence detection is carried out on the brain-like tissue cultured on the 7 th day, and the specific method comprises the following steps: sucking out the brain-like ball from the culture device by a 10ml pipette, and performing frozen section with the thickness of 8-10 μm; staining was then performed using IBA1 and DAPI, respectively, and on-machine observations.
The results are shown in FIG. 8. The green substance in the figure is NEUN, which is a marker of neurons in the brain-like, and represents the brain-like; in the figure, the red substance is IBA1, which is a marker of microglia and represents microglia. From the figure, a large number of microglial cells are delivered into the brain-like sphere along the upper microneedle, the fusion state of the microglial cells and the brain-like sphere is good, the deformation and apoptosis of tissues and cells are not seen under the scope, and the brain-like organ with immune cells is formed through continuous fusion.
Example 2: co-culture of endothelial cells and brain-like organs
1. Preparation of endothelial cells:
ipscs were differentiated into endothelial cells using the STEMdiff ™ Endothelial Differentiation Kit (08005, 08007) kit of stemell, and then added to the culture system in the same manner as described above for microglia. Co-culturing for 7 days. Obtaining the mixture of endothelial cells and brain-like cells.
2. The microglial cells in example 1 were replaced with the endothelial cells, and the other steps were the same, and the results are shown in fig. 9 and 10. As can be seen from fig. 9, after the 10-fold mirror is subjected to microneedle insertion co-culture, a large number of endothelial cells enter into the brain-like sphere, and after 7 days of co-culture, the endothelial cells are uniformly distributed at the center and the edge of the brain-like sphere due to the self-migration characteristic of the endothelial cells; it can be seen from fig. 10 that under a 100-fold mirror, endothelial cells have been locally connected together to form a primary-like vascular structure, constituting a vascularized brain-like organ.
In fig. 9 and 10, blue fluorescence stained DAPI nuclei and green stained cd31+ endothelial cells.
The present invention is described in detail above. It will be apparent to those skilled in the art that the present invention can be practiced in a wide range of equivalent parameters, concentrations, and conditions without departing from the spirit and scope of the invention and without undue experimentation. While the invention has been described with respect to specific embodiments, it will be appreciated that the invention may be further modified. In general, this application is intended to cover any variations, uses, or adaptations of the invention following, in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains. The application of some of the basic features may be done in accordance with the scope of the claims that follow.
Claims (10)
1. A micro-needle array-based organoid culture method, characterized in that an organoid culture device is used, wherein the organoid culture device comprises a lower piece for culturing organoids and a middle piece with micro-needles for culturing cell tissues; the lower part is detachably connected with the middle part, and the cell tissues cultured in the middle part are communicated with the organoids in the lower part through the microneedles; the method comprises the following steps:
1) Placing the organoids in the lower part for culture;
2) The middle piece is arranged above the lower piece, cells are added into the middle piece, and the cells and the culture medium are transferred to the brain-like ball at the tail end of the micro needle by utilizing gravity through a micro needle passage and are diffused into brain-like tissues through the opening at the tail end of the micro needle.
2. The micro-needle array-based organoid culture method according to claim 1, wherein the lower part comprises a lower part base and a lower part base platform connected above the lower part base, a culture tank with an upper end opening is arranged on the base platform, and at least one organoid placement hole is arranged in the culture tank; a group partition plate is arranged between two adjacent organoid placing holes, the group partition plate is connected with the bottom wall of the culture tank, and a hole is arranged between the group partition plate and the side wall of the culture tank; the culture medium feeding device is characterized in that a lower culture medium feeding groove is arranged on the base, and the lower culture medium feeding groove is positioned on two sides of the culture groove and is communicated with the culture groove through a culture medium inlet.
3. The micro-needle array-based organoid culture method according to claim 2, wherein positioning piles are provided around the organoid placement hole; one side of the base station is provided with a positioning fillet.
4. The micro-needle array-based organoid culture method according to claim 1, wherein the middle part comprises a middle part base and a middle part base platform connected above the middle part base, a middle part U-shaped liquid adding groove is arranged on the middle part base platform at a position corresponding to the culture groove of the lower part, at least 1 middle part cell culture chamber is arranged in the middle part U-shaped liquid adding groove, the micro-needle array is connected below the middle part cell culture chamber, the middle part cell culture chamber is communicated with the micro-needle array, and when the middle part is connected with the lower part, the lower end of the micro-needle array is inserted into the cerebid tissue cultured on the organoid placing hole.
5. The micro-needle array-based organoid culture method according to claim 4, wherein the middle piece base is provided with an upward concave groove matched with the edge of the lower piece base, and the side of the groove corresponding to the positioning fillet of the lower piece base is provided with an arc inner angle.
6. The microneedle array based organoid culture method of claim 1, wherein the device comprises a top piece for closing the device, the top piece being removably attached to the middle piece.
7. The micro-needle array-based organoid culture method according to claim 6, wherein the upper member is a cover body connected above the middle member, and an upper cover supporting block is arranged on the inner surface of the cover body; one side of the middle part base station is a round angle, and one side of the upper part corresponding to the round angle of the middle part base station is provided with an arc inner angle.
8. The microneedle array based organoid culture method of any of claims 1-7, wherein said step 1) is specifically:
11 Input matrigel): firstly, injecting matrigel into an organoid placing hole of a lower piece by using a liquid transfer device;
12 Placement of organoids: carefully placing the organoids in organoid placement holes filled with matrigel;
13 Injection medium: organoid medium was placed into the organoid through the lower feed tank Kong Jiazhu medium.
9. The microneedle array based organoid culture method of claim 8, wherein said step 2) is specifically:
21 Positioning round corners of the middle piece and the lower piece to be aligned, and slowly pressing the middle piece into the lower piece;
22 Culturing microglial cells in medium: transferring a culture medium of microglial cells into a middle piece U-shaped liquid adding groove, and sequentially inoculating the microglial cells into a middle piece cell culture chamber by using a liquid transfer device;
23 Microglial cell-mixed culture medium is transferred to the organoid at the end of the microneedle through the microneedle channel by utilizing gravity and is diffused into the organoid tissue through the opening at the end of the microneedle.
10. The microneedle array based organoid culture method of any of claims 1-9, wherein the organoid is a brain-like organ.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311653619.8A CN117384759B (en) | 2023-12-05 | 2023-12-05 | Micro-needle array-based organoid culture method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311653619.8A CN117384759B (en) | 2023-12-05 | 2023-12-05 | Micro-needle array-based organoid culture method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117384759A true CN117384759A (en) | 2024-01-12 |
| CN117384759B CN117384759B (en) | 2024-03-29 |
Family
ID=89470502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311653619.8A Active CN117384759B (en) | 2023-12-05 | 2023-12-05 | Micro-needle array-based organoid culture method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117384759B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197575B1 (en) * | 1998-03-18 | 2001-03-06 | Massachusetts Institute Of Technology | Vascularized perfused microtissue/micro-organ arrays |
| US20090286317A1 (en) * | 2006-09-14 | 2009-11-19 | Probiogen Ag | Modular culture system for maintenance, differentiation and proliferation of cells |
| CN111748443A (en) * | 2019-03-29 | 2020-10-09 | 北京大橡科技有限公司 | 3D multilayer high-throughput organ chip and preparation method and application thereof |
| US20230257689A1 (en) * | 2020-07-07 | 2023-08-17 | Redbud Labs, Inc. | Microscale bioreactor system for and method of providing cell culture growth conditions in a small-volume vessel |
| CN116622506A (en) * | 2023-04-19 | 2023-08-22 | 重庆大学 | Brain organoid culture chip and preparation method thereof and brain organoid culture method |
| CN117004559A (en) * | 2022-04-29 | 2023-11-07 | 北京干细胞与再生医学研究院 | Method for constructing brain and cardiac muscle composite model from human pluripotent stem cells |
-
2023
- 2023-12-05 CN CN202311653619.8A patent/CN117384759B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197575B1 (en) * | 1998-03-18 | 2001-03-06 | Massachusetts Institute Of Technology | Vascularized perfused microtissue/micro-organ arrays |
| US20090286317A1 (en) * | 2006-09-14 | 2009-11-19 | Probiogen Ag | Modular culture system for maintenance, differentiation and proliferation of cells |
| CN111748443A (en) * | 2019-03-29 | 2020-10-09 | 北京大橡科技有限公司 | 3D multilayer high-throughput organ chip and preparation method and application thereof |
| US20230257689A1 (en) * | 2020-07-07 | 2023-08-17 | Redbud Labs, Inc. | Microscale bioreactor system for and method of providing cell culture growth conditions in a small-volume vessel |
| CN117004559A (en) * | 2022-04-29 | 2023-11-07 | 北京干细胞与再生医学研究院 | Method for constructing brain and cardiac muscle composite model from human pluripotent stem cells |
| CN116622506A (en) * | 2023-04-19 | 2023-08-22 | 重庆大学 | Brain organoid culture chip and preparation method thereof and brain organoid culture method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117384759B (en) | 2024-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lin et al. | A microfluidic dual-well device for high-throughput single-cell capture and culture | |
| US20220033757A1 (en) | Open-top microfluidic device with structural anchors | |
| Zheng et al. | Organ‐on‐a‐Chip Systems: microengineering to biomimic living systems | |
| Tehranirokh et al. | Microfluidic devices for cell cultivation and proliferation | |
| Huang et al. | Brain slice on a chip: opportunities and challenges of applying microfluidic technology to intact tissues | |
| KR101756901B1 (en) | Cell culture chip and method of skin model | |
| CN108410797A (en) | The expanding stem cells in hollow-fiber bioreactor | |
| CN111218404A (en) | Bionic multi-organ chip and preparation method and application thereof | |
| Melin et al. | In vitro embryo culture in defined, sub‐microliter volumes | |
| US20190062686A1 (en) | Microfluidic device for culturing cells | |
| US20170211029A1 (en) | Neurovascular unit(nvu)-on-a-chip and method of fabricating the same | |
| KR20210024342A (en) | Endomysium scaled heart on a chip for drug efficacy and toxicity test | |
| Joshi | Cells and organs on chip—A revolutionary platform for biomedicine | |
| KR20170087837A (en) | NeuroVascular Unit(NVU)-On-a-Chip And Method Of Fabricating The Same | |
| CN117004559A (en) | Method for constructing brain and cardiac muscle composite model from human pluripotent stem cells | |
| CN112852627A (en) | Method for co-culturing pluripotent stem cells from human liver and pancreatic islets based on multi-organ chip | |
| CN117384759B (en) | Micro-needle array-based organoid culture method | |
| CN212316139U (en) | Bionic multi-organ chip | |
| CN104893953A (en) | Adherent cell scratch making and migration observing methods based on micro-fluidic chip | |
| CN117363482B (en) | Method for combined culture of different kinds of organoids | |
| Liu et al. | Advances in Microfluidic Technologies in Organoid Research | |
| Hsiao | 3D spheroid culture systems for metastatic prostate cancer dormancy studies and anti-cancer therapeutics development | |
| CN113717850A (en) | Non-alcoholic fatty liver in-vitro model building method based on three-dimensional liver-like chip | |
| CN116445282B (en) | Microfluidic system and application thereof in constructing bionic organ microenvironment | |
| Pham et al. | Microfluidic Culture Platforms in Neuroscience Research |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |